IW

Irving L. Weissman

Stanford University: 130 patents #1 of 5,197Top 1%
SY Systech: 7 patents #14 of 217Top 7%
University of California: 7 patents #1,047 of 18,278Top 6%
SC Stemcells California: 4 patents #2 of 10Top 20%
FS Forty Seven: 4 patents #4 of 17Top 25%
TT The University Of Tokyo: 2 patents #500 of 2,633Top 20%
Caltech: 2 patents #1,302 of 4,321Top 35%
Harvard University: 1 patents #1,740 of 3,600Top 50%
TU Tufts University: 1 patents #72 of 247Top 30%
ST Stemcells: 1 patents #4 of 5Top 80%
📍 Stanford, CA: #3 of 1,454 inventorsTop 1%
🗺 California: #1,038 of 386,348 inventorsTop 1%
Overall (All Time): #6,518 of 4,157,543Top 1%
146
Patents All Time

Issued Patents All Time

Showing 51–75 of 146 patents

Patent #TitleCo-InventorsDate
10995152 Modified immunoglobulin hinge regions to reduce hemagglutination Jie Liu, Ravindra Majeti 2021-05-04
10942185 Therapeutic and diagnostic methods for manipulating phagocytosis through calreticulin and low density lipoprotein-related receptor Mark P. Chao, Rachel Weissman-Tsukamoto, Siddhartha Jaiswal, Ravindra Majeti 2021-03-09
10934355 Methods and compositions for the prevention and treatment of surgical adhesions Jonathan Tsai, Nathaniel Fernhoff, Rahul Sinha, Yuval Rinkevich 2021-03-02
10934331 Methods for enhancing immune responsiveness in an individual toward a target cancer cell population comprising apoptotic cells Daniel Mark COREY, Aaron Michael Ring, Melissa N. McCracken 2021-03-02
10894831 Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonist Peter Schnorr, Akanksha Chhabra, Judith A. Shizuru, Kipp Andrew Weiskopf 2021-01-19
10889649 Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance Roy Louis Maute, Kipp Andrew Weiskopf, Aaron Michael Ring 2021-01-12
10822411 Targeting aneurysm disease by modulating phagocytosis pathways Nicholas J. Leeper 2020-11-03
10800830 High affinity PD-1 agents and methods of use Aaron Michael Ring, Andrew Kruse, Aashish Manglik, Roy Louis Maute, Melissa N. McCracken +1 more 2020-10-13
10787640 Producing mesodermal cell types and methods of using the same Kyle M. Loh, Lay Teng Ang, Angela Chen 2020-09-29
10781256 Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies Kipp Andrew Weiskopf, Aaron Michael Ring, Jens-Peter Volkmer, Nan Guo Ring 2020-09-22
10780117 Macrophages eat cancer cells using their own calreticulin as a guide Mingye Feng, Jens-Peter Volkmer 2020-09-22
10723803 CD47 targeted therapies for the treatment of infectious disease Kipp Andrew Weiskopf, Kim J. Hasenkrug, Cheryl A. Stoddart, Joseph M. McCune 2020-07-28
10662242 Markers of acute myeloid leukemia stem cells Ravindra Majeti 2020-05-26
10645912 Method for producing chimeric animal Hiromitsu Nakauchi, Hideki Masaki, Motoo WATANABE 2020-05-12
10640561 Methods for manipulating phagocytosis mediated by CD47 Siddhartha Jaiswal, Ravindra Majeti, Mark P. Chao 2020-05-05
10618976 SIRP-α agonist antibody Benson M. George, Nan Guo Ring, Aaron Michael Ring, Jens-Peter Volkmer 2020-04-14
10611842 Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPα antibody therapy Jie Liu, Aaron Michael Ring, Jens-Peter Volkmer 2020-04-07
10543235 Pericytes are intermediate progenitors for epicardial derived coronary artery smooth muscle Kristy Red-Horse, Katharina Volz 2020-01-28
10406179 Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling Judith A. Shizuru, Kipp Andrew Weiskopf, Aaron Michael Ring, Akanksha Chhabra, Peter Schnorr 2019-09-10
10386361 Long term hematopoietic stem cell specific reporter mouse and uses thereof James Y. Chen, Masanori Miyanishi 2019-08-20
10358472 High affinity CD47 analogs Chia Chi Ho, Kenan Christopher Garcia, Aaron Michael Ring, Kipp Andrew Weiskopf, Nan Guo Ring 2019-07-23
10344094 Treatment of cancer with dual targeting of CD47 and EGFR Stephen Willingham, Doris Po Yi Ho, Piero D. Dalerba, Kelly Marie McKenna, Jens-Peter Volkmer 2019-07-09
10329354 Modulation of efferocytosis pathways for treatment of atherosclerotic disease Nicholas J. Leeper 2019-06-25
10316094 Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance Roy Louis Maute, Kipp Andrew Weiskopf, Aaron Michael Ring 2019-06-11
10301387 Methods for achieving therapeutically effective doses of anti-CD47 agents Stephen Willingham, Maureen Howard, Jie Liu, Ravindra Majeti, Susan Sweeney Prohaska +2 more 2019-05-28